Myriad Genetics
MYGN
#6699
Rank
โ‚ฌ0.56 B
Marketcap
6,09ย โ‚ฌ
Share price
-3.27%
Change (1 day)
-57.48%
Change (1 year)

Myriad Genetics (MYGN) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ0.62 Billion

According to Myriad Genetics's latest financial reports the company's total assets are โ‚ฌ0.62 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Myriad Genetics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ0.98 B-4.79%
2023-12-31โ‚ฌ1.03 B-7.19%
2022-12-31โ‚ฌ1.11 B-4.18%
2021-12-31โ‚ฌ1.16 B
2020-06-30โ‚ฌ1.25 B-9.09%
2019-06-30โ‚ฌ1.37 B36.92%
2018-06-30โ‚ฌ1.00 B-5.21%
2017-06-30โ‚ฌ1.05 B33.63%
2016-06-30โ‚ฌ0.79 B15.22%
2015-06-30โ‚ฌ0.68 B14.38%
2014-06-30โ‚ฌ0.60 B-2.6%
2013-06-30โ‚ฌ0.61 B13.21%
2012-06-30โ‚ฌ0.54 B29.49%
2011-06-30โ‚ฌ0.42 B-11.26%
2010-06-30โ‚ฌ0.47 B43.96%
2009-06-30โ‚ฌ0.32 B4.01%
2008-06-30โ‚ฌ0.31 B13.49%
2007-06-30โ‚ฌ0.27 B27.95%
2006-06-30โ‚ฌ0.21 B63.97%
2005-06-30โ‚ฌ0.13 B-14.01%
2004-06-30โ‚ฌ0.15 B-3.11%
2003-06-30โ‚ฌ0.15 B0.77%
2002-06-30โ‚ฌ0.15 B-21.71%
2001-06-30โ‚ฌ0.20 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Bio-Rad Laboratories
BIO
โ‚ฌ8.32 B 1,231.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
โ‚ฌ5.06 B 710.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
โ‚ฌ18.98 M-96.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ6.54 B 945.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ72.30 B 11,461.74%๐Ÿ‡บ๐Ÿ‡ธ USA